AMERICAN JOURNAL OF HYPERTENSION

Scope & Guideline

Elevating standards in hypertension care and research.

Introduction

Immerse yourself in the scholarly insights of AMERICAN JOURNAL OF HYPERTENSION with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0895-7061
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Converge1954, from 1988 to 2024
AbbreviationAM J HYPERTENS / Am. J. Hypertens.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The American Journal of Hypertension primarily focuses on advancing the understanding, diagnosis, and treatment of hypertension through innovative research and clinical insights. It serves as a platform for high-quality studies that explore a wide range of topics related to hypertension, including its pathophysiology, epidemiology, treatment strategies, and the impact of social determinants on hypertension management.
  1. Clinical Research and Trials:
    The journal emphasizes original clinical research and randomized controlled trials that provide evidence-based insights into hypertension management and treatment efficacy.
  2. Pathophysiological Mechanisms:
    Investigations into the biological and physiological mechanisms underlying hypertension, including studies on vascular function, renal mechanisms, and hormonal influences.
  3. Epidemiology and Public Health:
    Research on the prevalence, risk factors, and socio-economic determinants of hypertension, aiming to inform public health strategies and interventions.
  4. Innovative Treatment Approaches:
    Exploration of novel pharmacological and non-pharmacological treatment options for hypertension, including lifestyle modifications and new drug classes.
  5. Technological Advancements:
    Integration of technology in hypertension management, such as telemonitoring, mobile health applications, and wearable devices for blood pressure monitoring.
  6. Health Disparities:
    Focus on understanding and addressing racial, ethnic, and socio-economic disparities in hypertension prevalence and management.
The American Journal of Hypertension has been evolving, with several emerging themes gaining traction in recent publications. These trends reflect a broader understanding of hypertension's complexities and a more holistic approach to its management.
  1. Multifactorial Approaches to Hypertension Management:
    An increasing number of studies focus on the interplay of genetic, environmental, and lifestyle factors in hypertension, emphasizing a multifaceted approach to treatment.
  2. Impact of Social Determinants of Health:
    Research highlighting the influence of social determinants, such as socioeconomic status and access to care, on hypertension outcomes is becoming more prominent.
  3. Hypertension in Special Populations:
    Emerging studies are focusing on hypertension in specific populations, including pregnant women, children, and ethnic minorities, addressing unique challenges and treatment responses.
  4. Technological Integration in Hypertension Care:
    There is a growing interest in the use of digital health technologies, such as telehealth and mobile health applications, to enhance hypertension management and patient engagement.
  5. Comorbidities and Hypertension:
    The relationship between hypertension and other chronic conditions, such as diabetes and cardiovascular diseases, is increasingly being explored, emphasizing comprehensive patient management.
  6. Patient-Centered Care and Experiences:
    Research focusing on patient experiences, preferences, and adherence to hypertension treatment is gaining traction, reflecting a shift towards more personalized care.

Declining or Waning

While the American Journal of Hypertension has a robust focus on various aspects of hypertension research, certain themes appear to be declining in prominence over recent years. This decline may reflect shifts in research interests or emerging priorities within the field.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies solely focusing on traditional antihypertensive medications, as newer treatment strategies and combination therapies gain attention.
  2. Static Risk Factor Analysis:
    Research that solely addresses static risk factors for hypertension, such as age and BMI, is becoming less common, with a shift toward more dynamic and multifactorial approaches.
  3. Basic Science Studies:
    There is a waning interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes translational and clinical research.
  4. Longitudinal Cohort Studies:
    Although still valuable, there appears to be a decrease in the publication of large longitudinal cohort studies that focus solely on hypertension without incorporating intervention strategies.

Similar Journals

Nature Reviews Cardiology

Transforming Cardiology with Rigorous Research and Open Access
Publisher: NATURE PORTFOLIOISSN: 1759-5002Frequency: 12 issues/year

Nature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.

Advances in Rheumatology

Unlocking the potential of rheumatology through open access.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Journal of the Practice of Cardiovascular Sciences

Pioneering Insights for Cardiovascular Excellence
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.

BLOOD PRESSURE

Transforming blood pressure knowledge into clinical excellence.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-7051Frequency: 6 issues/year

BLOOD PRESSURE is a distinguished journal published by Taylor & Francis Ltd in the field of cardiology and internal medicine, with an ISSN of 0803-7051 and E-ISSN of 1651-1999. Since its inception in 1992, it has become a vital source of research and clinical information, dedicated to advancing our understanding of blood pressure-related health issues. With a notable categorization of Q3 in Cardiology and Cardiovascular Medicine and Q2 in Internal Medicine as of 2023, this journal exemplifies a commitment to evidence-based findings that impact clinical practice and patient care. The journal facilitates a platform for original research, reviews, and case studies, aiming to bridge the gap between researchers and practitioners. Although it does not currently offer open access, BLOOD PRESSURE remains an essential resource for professionals and students alike, striving to enhance health outcomes through dedication to innovative cardiovascular research.

JOURNAL OF HUMAN HYPERTENSION

Innovating insights into hypertension for healthcare professionals.
Publisher: SPRINGERNATUREISSN: 0950-9240Frequency: 12 issues/year

JOURNAL OF HUMAN HYPERTENSION, a prominent publication in the field of internal medicine, is dedicated to advancing the understanding of hypertension and its implications for human health. Published by SPRINGERNATURE in the United Kingdom, this esteemed journal has been a vital resource for researchers and clinicians since its inception in 1987, with a continuous commitment to disseminating high-quality, peer-reviewed research. With an impressive Q2 category rank in Internal Medicine and a Scopus rank of 53 out of 167, it occupies a crucial position within the academic community, reaching a 68th percentile ranking that underscores its significance. The journal aims to provide a platform for innovative studies and reviews, fostering knowledge that bridges basic science, clinical practice, and public health. Although it does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital information about hypertension is available to a broad spectrum of healthcare professionals and researchers. Explore the critical findings and groundbreaking research published in the JOURNAL OF HUMAN HYPERTENSION to stay at the forefront of hypertension studies.

Russian Open Medical Journal

Empowering healthcare through open access and collaboration.
Publisher: SCIENCE & INNOVATION, LTDISSN: 2304-3415Frequency: 4 issues/year

Russian Open Medical Journal is an esteemed academic publication launched in 2012 by SCIENCE & INNOVATION, LTD, dedicated to advancing the field of medicine and promoting innovative research. As an Open Access journal, it ensures that knowledge is freely accessible to all, fostering collaboration and dissemination of vital medical findings. Based in the Russian Federation, this journal covers a wide array of topics under the domain of general medicine and contributes to the global medical discourse with its commitment to quality research dissemination. With a current Scopus rank of #368 out of 636 in the category of General Medicine, placing it in the 42nd percentile, the journal demonstrates a growing impact within the scientific community. Researchers, healthcare professionals, and students seeking to explore contemporary medical issues will find this journal a valuable resource, reflecting a global perspective while emphasizing innovative solutions to health challenges.

Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Innovating Women's Health: Cardiovascular Insights for Expecting Mothers
Publisher: ELSEVIER SCI LTDISSN: 2210-7789Frequency: 4 issues/year

Pregnancy Hypertension – An International Journal of Women's Cardiovascular Health, published by Elsevier Science Ltd, is a leading platform dedicated to advancing the understanding of cardiovascular health in women during pregnancy and postpartum periods. With an ISSN of 2210-7789, this esteemed journal has distinguished itself in the fields of Internal Medicine and Obstetrics and Gynecology, maintaining a remarkable Q2 ranking in Internal Medicine and a prestigious Q1 ranking in Obstetrics and Gynecology as of 2023. It is recognized for its high-quality research, which fits within the top quartile of its categories, and spans from 2010 to 2024, reflecting its ongoing contribution to critical advancements in women's cardiovascular health. The journal is accessible to a global audience of researchers, practitioners, and students, emphasizing its commitment to promoting open scholarly communication, although it currently operates under traditional access. The publication serves as a crucial resource for those seeking to enhance their knowledge and practices related to the unique cardiovascular challenges faced by women during pregnancy, thereby fostering informed clinical approaches and improved health outcomes.

International Journal of Hypertension

Connecting knowledge and practice in hypertension care.
Publisher: HINDAWI LTDISSN: 2090-0384Frequency: 1 issue/year

The International Journal of Hypertension, published by HINDAWI LTD, is a pivotal open-access journal dedicated to advancing knowledge in the field of hypertension and cardiovascular health. Since its inception in 2010, the journal has provided a vital platform for researchers, clinicians, and students to disseminate innovative findings and comprehensive reviews spanning various aspects of hypertension management, pathophysiology, and epidemiology. Residing in Q3 of the Internal Medicine category and ranked 75 out of 167 in the Scopus rankings, it reflects a commitment to quality and relevance in medical research. With a global reach, the journal aims to foster collaboration and knowledge exchange, contributing significantly to the scientific community's efforts to combat hypertension-related health issues. Accessible since 2010, this journal exemplifies the principles of open science, ensuring that critical research is available to all stakeholders in the field.

SCHIZOPHRENIA BULLETIN

Connecting research and practice in schizophrenia studies.
Publisher: OXFORD UNIV PRESSISSN: 0586-7614Frequency: 6 issues/year

SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.

Cardiology in Review

Elevating cardiology through comprehensive scholarship.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1061-5377Frequency: 6 issues/year

Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.